Dr. Mack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Childrens Way 123
Little Rock, AR 72202Phone+1 501-364-2270Fax+1 501-364-2283
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Pediatric Hematology/Oncology, 2015 - 2018- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2012 - 2015
Ross University School of MedicineClass of 2012
Certifications & Licensure
AR State Medical License 2015 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study) Start of enrollment: 2022 Jul 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 11 citationsShort‐term side effects and patient‐reported outcomes of bleomycin sclerotherapy in vascular malformationsJoana M. Mack, Gresham T. Richter, David L. Becton, Omar Salem, Sarah E. Hill
Pediatric Blood & Cancer. 2018-06-01 - 4 citationsPharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations.Joana M Mack, Eric C Peterson, Shelley E Crary, Jeffery H Moran, Kathleen Neville
Pediatric Blood & Cancer. 2022-08-01 - 7 citationsHydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposureJeremie H. Estepp, Paweł Wiczling, Joseph Moen, Guolian Kang, Joana M. Mack
British Journal of Clinical Pharmacology. 2018-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
